Showing papers by "Darius Moradpour published in 1995"
TL;DR: Infection with hepatitis B virus (HBV) results in a broad spectrum of liver disease, ranging from subclinical infection to acute, self-limited hepatitis and fatal, fulminant hepatitis.
Abstract: Infection with hepatitis B virus (HBV) results in a broad spectrum of liver disease, ranging from subclinical infection to acute, self-limited hepatitis and fatal, fulminant hepatitis. Exposure to HBV, particularly when it occurs early in life, may also result in an asymptomatic carrier state that can progress to chronic active hepatitis, cirrhosis of the liver, and eventually hepatocellular carcinoma. Complex viral and host factors determine this variable clinical outcome. Fundamental questions about the biologic aspects of hepatitis B that have direct relevance to clinical practice remain unresolved. It is estimated that there are 400 to 500 million HBV carriers in . . .
51 citations
TL;DR: It is concluded that the MAb AF‐20 directs highly efficient, specific, and rapid targeting of immunoliposomes to human HCC and other human cancer cell lines in vitro, which represents a promising approach for the development of immunotargeted diagnosis and therapy strategies against HCC.
36 citations
1 citations